These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15371389)

  • 1. Prescription drug spending trends for the privately insured in Maryland, 2000-2001.
    Shaya FT; Blume S; Mullins CD
    Health Aff (Millwood); 2004; 23(5):226-32. PubMed ID: 15371389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Being uninsured in 1996 compared to 1987: how has the experience of the uninsured changed over time?
    Taylor AK; Cohen JW; Machlin SR
    Health Serv Res; 2001 Dec; 36(6 Pt 2):16-31. PubMed ID: 16148958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The decline in receipt of substance abuse treatment by the privately insured, 1992-2001.
    Mark TL; Coffey RM
    Health Aff (Millwood); 2004; 23(6):157-62. PubMed ID: 15537594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coverage for mental health treatment: do the gaps still persist?
    Zuvekas SH; Meyerhoefer CD
    J Ment Health Policy Econ; 2006 Sep; 9(3):155-63. PubMed ID: 17031020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic burden of prescription drug use among elderly patients in Ponce, Puerto Rico.
    López-Negrón L; Monsanto-Planadeball HA
    P R Health Sci J; 2006 Jun; 25(2):149-53. PubMed ID: 17203713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National health spending in 2004: recent slowdown led by prescription drug spending.
    Smith C; Cowan C; Heffler S; Catlin A
    Health Aff (Millwood); 2006; 25(1):186-96. PubMed ID: 16403753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National health spending in 2007: slower drug spending contributes to lowest rate of overall growth since 1998.
    Hartman M; Martin A; McDonnell P; Catlin A;
    Health Aff (Millwood); 2009; 28(1):246-61. PubMed ID: 19124877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Looking inside the nation's medicine cabinet: trends in outpatient drug spending by Medicare beneficiaries, 1997 and 2001.
    Moeller JF; Miller GE; Banthin JS
    Health Aff (Millwood); 2004; 23(5):217-25. PubMed ID: 15371388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health spending projections through 2013.
    Heffler S; Smith S; Keehan S; Clemens MK; Zezza M; Truffer C
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-79-93. PubMed ID: 15451969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does public insurance provide better financial protection against rising health care costs for families of children with special health care needs?
    Yu H; Dick AW; Szilagyi PG
    Med Care; 2008 Oct; 46(10):1064-70. PubMed ID: 18815528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic burdens: the persistently high out-of-pocket health care expenses faced by many Americans with chronic conditions.
    Cunningham PJ
    Issue Brief (Commonw Fund); 2009 Jul; 63():1-14. PubMed ID: 19626725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How much 'skin in the game' do medicare beneficiaries have? The increasing financial burden of health care spending, 1997-2003.
    Neuman P; Cubanski J; Desmond KA; Rice TH
    Health Aff (Millwood); 2007; 26(6):1692-701. PubMed ID: 17978388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada.
    Hanley GE; Morgan S
    Soc Sci Med; 2009 Mar; 68(5):919-24. PubMed ID: 19135288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recession led to a decline in out-of-pocket spending for children with special health care needs.
    Karaca-Mandic P; Yoo SJ; Sommers BD
    Health Aff (Millwood); 2013 Jun; 32(6):1054-62. PubMed ID: 23733979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic costs of benign prostatic hyperplasia in the private sector.
    Saigal CS; Joyce G
    J Urol; 2005 Apr; 173(4):1309-13. PubMed ID: 15758787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health spending projections through 2015: changes on the horizon.
    Borger C; Smith S; Truffer C; Keehan S; Sisko A; Poisal J; Clemens MK
    Health Aff (Millwood); 2006; 25(2):w61-73. PubMed ID: 16495287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in spending for substance abuse treatment, 1986-2003.
    Mark TL; Levit KR; Vandivort-Warren R; Coffey RM; Buck JA;
    Health Aff (Millwood); 2007; 26(4):1118-28. PubMed ID: 17630455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The financial burden from prescription drugs has declined recently for the nonelderly, although it is still high for many.
    Gellad WF; Donohue JM; Zhao X; Zhang Y; Banthin JS
    Health Aff (Millwood); 2012 Feb; 31(2):408-16. PubMed ID: 22323172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Savings from drug discount cards: relief for Medicare beneficiaries?
    Cubanski J; Frank RG; Epstein AM
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-198-209. PubMed ID: 15451980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.